WestEnd Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
WestEnd Advisors's AMGN Position: Q2 2026 in Review
WestEnd Advisors increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $2.4K and bringing the position to 48 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #77.
WestEnd Advisors first reported a position in AMGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $80.3M in Q3 2013. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- WestEnd Advisors held 48 shares of Amgen worth $17.4K as of Q2 2026.
- WestEnd Advisors bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
- Amgen made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #77 holding.
- WestEnd Advisors first reported a position in Amgen in Q2 2013 and has held it in 19 quarters since.
- WestEnd Advisors's Amgen position peaked at $80.3M in Q3 2013.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.